Pfizer Returns To Fray In Pharma Group's Wyeth Suit

Law360, New York (October 29, 2009, 2:46 PM EDT) -- Pfizer Inc. is again trying to fend off a lawsuit by a group of California pharmacies and pharmacists claiming the drugmaker's $68 billion buyout of rival Wyeth will eliminate competition and stifle innovation in the U.S. prescription drug market.

In a motion to dismiss filed Wednesday in the U.S. District Court for the Northern District of California, Pfizer and its Wyeth unit — which Pfizer acquired on Oct. 15 — accused the plaintiffs of engaging in “deja vu all over again” in filing an amended complaint...
To view the full article, register now.